Hjem › Livmodercancer › Texas
Livmodercancer kliniske forsøg i Texas
10 studier for Livmodercancer søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Texas Oncology - DFW, Arlington
- Texas Oncology - Central South, Austin
- Texas Oncology - Central South, Austin
- og 13 flere
RekruttererFase 4
Alder 18 og opefter · Kvinder · Opdateret 25. sep. 2026 · NCT06952660Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- M D Anderson Cancer Center, Houston
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT04038619Sentinel Node Biopsy in Endometrial Cancer
- Houston Methodist Hospital, Houston
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 15. sep. 2026 · NCT04073706DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Austin
- Research Site, Fort Worth
- Research Site, Houston
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 3. sep. 2026 · NCT06989112Investigations of Reproductive Cancers in Women
- Baylor College of Medicine/Texas Children's Hospital, Houston
- Houston Methodist, Houston
- University of Texas Health Science Center at San Antonio, San Antonio
RekruttererObservationsstudie
Alder 45 til 100 · Kvinder · Opdateret 17. aug. 2026 · NCT06527157Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Texas Oncology, Abilene
- Texas Oncology - Central / South Texas, Austin
- Mary Crowley Cancer Research, Dallas
- og 3 flere
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT05579366Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Austin
- Research Site, Houston
- Research Site, Tyler
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 29. jul. 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Baylor Scott & White Research Institute, Dallas
- University of Texas MD Anderson Cancer Center, Houston
- Baylor Scott & White Medical Center, Temple
RekruttererFase 2
Alder 8 og opefter · Alle køn · Opdateret 27. jul. 2026 · NCT05503797Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
- M D Anderson Cancer Center, Houston
RekruttererObservationsstudie
Alder 18 og opefter · Kvinder · Opdateret 6. maj 2026 · NCT05049538Sample Collection for Ongoing Research and Product Evaluation Study
- Natera, Inc., Austin
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 15. jan. 2026 · NCT07318051Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.